CCP110 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-26118
Key Product Details
Species Reactivity
Human
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence CEKSLARIQEAS corresponding to N-Terminus according to NP_001185951.1, NP_055526.3.
Specificity
This antibody is expected to recognize both reported isoforms (NP_001185951.1; NP_055526.3).
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for CCP110 Antibody
Western Blot: CCP110 Antibody [NBP2-26118]
Western Blot: CCP110 Antibody [NBP2-26118] - Staining of Human Testis lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for CCP110 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:32000
Western Blot
0.3 - 1 ug/ml
Application Notes
WB: Approx. 110 kDa band observed in human testis lysates (calculated MW of 113 kDa band according to NP_001185951.1).
Additional bands of unknown identity were also consistently observed at 65 kDa band and 37 kDa. These bands were successfully blocked by incubation with the immunizing peptide.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: CCP110
Alternate Names
centriolar coiled coil protein 110kDa, Cep110, CP110
Entrez Gene IDs
9738 (Human)
Gene Symbol
CCP110
Additional CCP110 Products
Product Documents for CCP110 Antibody
Product Specific Notices for CCP110 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...